New Key Statistics Module, Z-Score and F-Score
SZSE:300972 Key Ratios
Market Cap ¥ M | 14,723.16 |
Enterprise Value ¥ M | 13,794.08 |
P/E(ttm) | 281.10 |
PE Ratio without NRI | 206.57 |
Forward PE Ratio | 26.45 |
Price/Book | 16.07 |
Price/Sales | 0.52 |
Price/Free Cash Flow | 6.48 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 25,006.00 |
EPS (TTM) ¥ | 0.29 |
Beneish M-Score | -1.52 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -8.40 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 20.50 |
EV-to-EBITDA | 20.50 |
PEG | -- |
Shares Outstanding M | 179.99 |
Net Margin (%) | 0.23 |
Operating Margin % | 2.81 |
Pre-tax Margin (%) | 2.48 |
Quick Ratio | 0.68 |
Current Ratio | 1.07 |
ROA % (ttm) | 1.30 |
ROE % (ttm) | 7.12 |
ROIC % (ttm) | 15.40 |
Dividend Yield % | -- |
Altman Z-Score | 5.79 |
SZSE:300972 Number of Guru Trades
SZSE:300972 Volume of Guru Trades
Gurus Latest Trades with SZSE:300972
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300972 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Fujian Wanchen Biotechnology Group Co Ltd Insider Transactions
No Available Data